EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

A One Health approach to overcoming fungal disease and antifungal resistance

Michael Woods, Jason A McAlister, Jennifer Geddes-McAlister iD

WIREs Mechanisms of Disease · 2023-07 · 15 (4)

DOI: 10.1002/wsbm.1610 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift WIREs Mechanisms of Disease, online erschienen am 26.04.2023. Verfasst von Michael Woods und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada. Hauptthemen laut MEDLINE: One Health, Mycoses, Fungicides, Industrial. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Institute of Infection and Immunity, Ontario Ministry of Agriculture, Food and Rural Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global burden of fungal disease poses a substantial threat to human, animal, and environmental health, endangering both human and livestock populations and creating vulnerabilities to food supplies world‐wide. Antifungal drugs provide essential therapies to humans and animals against infections, while fungicides provide protection in agriculture. However, a limited arsenal of antifungal agents results in cross‐use between agriculture and health, promoting the development of resistance, and drastically reducing our defenses against disease. Critically, antifungal resistant strains found ubiquitously within the natural environment demonstrate resistance to the same classes of antifungals used to treat human and animal infections, hindering effective treatment within the clinic. This interconnectivity supports the need for a One Health approach to combat fungal diseases and overcome antifungal resistance, ensuring that treatment and protection of a defined group does not inadvertently endanger or sacrifice other plants, animals, or humans. In this review, we present sources of antifungal resistance and discuss the integration of environmental and clinical resources to manage disease. Moreover, we explore opportunities for drug synergy and repurposing strategies, highlight fungal targets being investigated to overcome resistance, and propose technologies for the discovery of novel fungal targets. This article is categorized under: Infectious Diseases > Molecular and Cellular Physiology

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

One HealthMycosesFungicides, IndustrialAnimalsHumansAntifungal AgentsDrug Resistance, Fungal

Stichwörter der Autor:innen

One Healthantifungal resistancefood securityfungal diseaseglobal health

Substanzen

Antifungal AgentsFungicides, Industrial

Autor:innen und Institutionen

  • Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.

ORCID-Profile: Jennifer Geddes-McAlister

Förderung

  • CIHR
  • Institute of Infection and Immunity
  • Ontario Ministry of Agriculture, Food and Rural Affairs

Zitieren

APA

Woods, M., McAlister, J. A., & Geddes-McAlister, J. (2023). A One Health approach to overcoming fungal disease and antifungal resistance. WIREs Mechanisms of Disease, 15(4). https://doi.org/10.1002/wsbm.1610

Vancouver

Woods M, McAlister JA, Geddes-McAlister J. A One Health approach to overcoming fungal disease and antifungal resistance. WIREs Mechanisms of Disease. 2023;15(4). doi:10.1002/wsbm.1610

BibTeX
@article{Woods2023,
  author = {Woods, Michael and McAlister, Jason A and Geddes-McAlister, Jennifer},
  title = {A One Health approach to overcoming fungal disease and antifungal resistance},
  journal = {WIREs Mechanisms of Disease},
  year = {2023},
  volume = {15},
  number = {4},
  doi = {10.1002/wsbm.1610}
}
Kostenlos starten →